Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

33.06
-0.7100-2.10%
Post-market: 33.060.00000.00%16:10 EDT
Volume:4K
Turnover:120.06K
Market Cap:42.15M
PE:- -
High:33.72
Open:33.72
Low:32.84
Close:33.77
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.56
T/O Rate:0.28%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Yesterday

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Yesterday

Legend Biotech Corporation - Alan Bash to Resume Role as President, Carvykti

THOMSON REUTERS
·
Yesterday

Legend Biotech Corporation - Appoints Ingrid Zhang as CEO Effective September 15, 2026

THOMSON REUTERS
·
Yesterday

Press Release: Legend Biotech Appoints Ingrid Zhang as Chief Executive Officer

Dow Jones
·
Yesterday

Legend Biotech is Expected to Name Ingrid Zhang as Its New Chief Executive - WSJ

THOMSON REUTERS
·
Yesterday

Berenberg Upgrades Eli Lilly and Co. to Buy From Hold, Adjusts Price Target to $1,400 From $1,220

MT Newswires Live
·
Yesterday

Barclays downgrades Scholar Rock on valuation after FDA approval

TIPRANKS
·
Yesterday

Lilly Gains After Berenberg Upgrades to 'buy' on Obesity Pill Momentum

Reuters
·
Yesterday

Eli Lilly : Berenberg Raises to Buy from Hold; Raises Target Price to $1,400 from $1,220

THOMSON REUTERS
·
Yesterday

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Yesterday

Ascendis Pharma Regains Rights to Weight-Loss Technology; Share Buyback Approved

Dow Jones
·
Yesterday

Ascendis Pharma to regain rights to TransCon technology-based products

TIPRANKS
·
Yesterday

Ascendis Pharma announces $400M share repurchase plan

TIPRANKS
·
Yesterday

Ascendis Pharma a/S - to Regain Exclusive Rights to Transcon Technology in Metabolic and Cardiovascular Diseases

THOMSON REUTERS
·
Yesterday

Press Release: Ascendis Announces Planned $400 Million Share Repurchase Program

Dow Jones
·
Yesterday

Rhythm Pharmaceuticals Coverage Assumed by Leerink Partners at Outperform

Dow Jones
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Yesterday